15 Jun 2022 --- US-based Balchem is acquiring Norwegian Kappa Bioscience from Verdane Edda for 3.175B NOK (US$338 million – at the time of the acquisition). A definite agreement has been signed, and Kappa Bioscience will be part of the human nutrition and health business segment.